Researchers from the UCLA School of Dentistry and the David Geffen School of Medicine at UCLA have been awarded $ 5 million over five years from the National Cancer Institute to develop liquid biopsy tools for testing individuals who could have lung cancer — the leading cause of cancer death in both U.S. men and women. The award, one of only six given in the nation, will support further development of the tools to improve methods for early detection of lung cancer.Today ’s standard of care in diagnosing lung cancer involves a low-dose computed tomography scan of the lungs, evaluating whether there are what are called “indeterminate lung nodules” and following these nodules over time to assess whether they begin to look suspicious for lung cancer. The challeng e of evaluating indeter…
MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
